Quantification of A. fumigatus-specific CD154+ T-cells-preanalytic considerations

S Wurster1, P Weis1, L Page1

  • 1University Hospital of Wuerzburg, Department of Internal Medicine II, Infectious Diseases, Oberduerr-bacher Str. 6, 97080 Wuerzburg, Germany.

Medical Mycology
|August 4, 2016
PubMed

Insights

Delayed sample processing significantly reduces detection of fungal specific CD154+ T-cells, a biomarker for invasive aspergillosis. Freezing peripheral blood mononuclear cells (PBMCs) preserves assay reliability for later analysis.

Area of Science:

  • Immunology
  • Clinical Microbiology
  • Medical Diagnostics

Background:

  • CD154+ T-cells are recognized as a biomarker for invasive aspergillosis.
  • The impact of sample storage conditions on detecting these specific immune cells requires investigation.

Purpose of the Study:

  • To evaluate the effect of sample storage delays on the detection of fungal-specific CD154+ T-cells.
  • To determine if freezing peripheral blood mononuclear cells (PBMCs) is a viable alternative for preserving assay reliability.

Main Methods:

  • Assessing cell viability and composition after a six-hour delay in PBMC isolation.
  • Quantifying CD154+ Aspergillus fumigatus specific cells using flow cytometry.
  • Comparing assay results from fresh PBMCs versus those stored at -20°C and -80°C.

Main Results:

  • A six-hour delay before PBMC isolation decreased cell viability by 18% and altered cellular composition.
  • Delayed processing led to an 87% reduction in detectable CD154+ A. fumigatus specific cells.
  • Freezing PBMCs at -20°C or -80°C allowed for later processing with comparable assay reliability (Pearson-Coefficient: 0.962).

Conclusions:

  • Prompt PBMC isolation is crucial for accurate detection of fungal-specific CD154+ T-cells.
  • Freezing PBMCs offers a reliable method for preserving these cells for later analysis when immediate processing is not possible.

Related Concept Videos